It was great to do this podcast. Persistent #viruses - and many bacteria, fungi and even parasite pathogens - directly hijack our #mitochondria. They can hack and distort human gene signaling that controls senescence & inflammaging. This knowledge is huge for longevity treatments
The reason is that the topic of the Summit is “Pathogen Persistence Across Chronic Disease & Aging”, and unfortunately that topic has been understudied in ME/CFS. We are working hard to change that via studies like this: https://t.co/73BhghVdbO But we don’t have all the data yet. So hopefully there will be talks on ME/CFS and pathogen persistence at next year’s Summit
Great to be featured last night on @WCVB along with amazing PolyBio funder & collaborator Steve Pagliuca. We are working hard to validate novel #diagnostic tests and treatments for the millions of patients around the world suffering from Long COVID & Chronic Lyme disease @pagsceltics@JessicaBrownTV https://t.co/bXhBrjg3G4
Persistent viral, bacterial, parasite & other #infections are increasingly implicated in chronic diseases and aging
We’ve united the top scientists, biotech innovators, and other stakeholders working to study & treat these infections into a 3-day Summit.
Come watch the talks virtually at the link below! 👇
We’re pleased to announce the inaugural PolyBio Convergence Summit will take place this November 18 to 20.
Presentations will explore the latest advances in persistent infections and their emerging roles in conditions such as Long COVID, chronic Lyme disease, multiple sclerosis, Alzheimer’s, and aging. Discussions will focus on the practical challenges that must be addressed to translate these discoveries into validated diagnostics, clinical trials, and effective therapies.
Add the virtual schedule to your calendar here: https://t.co/rCydfm3p3L
Breaking: PolyBio-Supported Preprint Finds Persistently Activated Virus-Specific T cells in a Subset of People with Long COVID
👉🏻Virus-specific immune cells show signs of ongoing stimulation and impaired function in a subset of people with Long COVID, offering a potential way to guide targeted clinical trials
1/
Breaking: Steve and Judy Pagliuca and Governor Maura Healey Accelerate Major Effort to Deliver Treatments for Long COVID $15 million raised by a coalition of donors to advance diagnostics and clinical trials for Long COVID; with the infrastructure expanding into chronic Lyme disease
1/
In collaboration with the LA Times, Drs. Amy Proal and Tim Henrich discussed the latest tissue-based research approaches to investigate underlying drivers of Long COVID.
“If we’re really going to understand what’s happening and where [SARS-CoV-2] is persisting… we really need to understand what’s happening in these tissues,” said Henrich, co-Principal Investigator in USCF’s PolyBio-supported LIINC tissue program.
“We’re also trying to develop non-invasive means… using PET imaging, to look at different immune activation states, or maybe even look for the virus itself… These studies are currently in progress so we don’t have to put people through these biopsies, or ask for invasive procedures when we can do this in a non-invasive state.”
Breaking: New Study Reveals Substantial Tissue-Level Immune Dysfunction Near Persistent Viral Reservoirs in Long COVID
👉🏻PolyBio-funded UCSF research finds persistent SARS-CoV-2 RNA alongside an altered gut immune response that may impair viral clearance 1/
@femalelongevity It’s great if you are testing for persistent infection several times a year as part of optimizing your fitness. I’d love to come on your podcast to discuss! Thanks for DMing me about it
It's madness that most people in the healthspan-extension space do little to control the activity of #viral, bacterial, #parasite and other pathogens that can hack their bodies over time.
Come listen to me talk at the Liberty Hotel next Thurs where I will discuss how to change this by optimizing anti-pathogen treatment approaches!
https://t.co/6XIhPz54tB
@_bjv__ We are funding a $1M ME/CFS program at UCSF that includes a large gut tissue analysis project designed to determine if we can replicate John Chia’s findings. We even worked with John on the design of the program: https://t.co/bYLeChjIdQ
Check out these talk summaries from our recent PolyBio Symposium👇
Highlights include that four groups — Tim Henrich (UCSF), Marcus Buggert (Karolinska), Nicolas Huot (Institut Pasteur), and Esen Sefik (Yale) — presented different lines of evidence (human gut biopsies, non-human primate models, humanized mice) all pointing to the same conclusion: SARS-CoV-2 persists in #LongCovid gut tissue and adjacent lymphoid structures, and that persistence drives ongoing immune dysregulation.
Written summaries of PolyBio’s Spring symposium presentations are available now! Check out shortened, simplified summaries, or full technical explanations of your favourite research projects.
Interactive resource: https://t.co/3pQ5BlIVQb
#longcovidresearch#mecfsresearch #lymeresearch
7/ Additional work is investigating whether SARS-CoV-2 persists within vascular tissue itself, potentially sustaining chronic inflammation and cardiovascular risk.
Hey! If you’re in Boston check out my talk this Tues at @LongevityGL Aging Code Summit
I’ll overview mechanisms by which persistent infections can accelerate human aging processes. This includes how viruses, parasites & other pathogens directly hijack our mitochondrial activity